{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T04:13:02Z","timestamp":1728965582208},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,14]]},"DOI":"10.7759\/cureus.71448","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:44:32Z","timestamp":1728920672000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of Low Vitamin D Status With Adiponectin and Fibroblast Growth Factor-21 in Newly Diagnosed Type 2 Diabetes Mellitus Patients"],"prefix":"10.7759","author":[{"given":"Visakamutharasi","family":"Murugiah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravati","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayaprakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nivedita","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suryanarayana  B","family":"Shamanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India","volume":"69","author":"Pradeepa R","year":"2021","unstructured":"Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021, 69:2932-8. 10.4103\/ijo.IJO_1627_21","journal-title":"Indian J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02658.x","article-title":"Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus","volume":"65","author":"Sharma PK","year":"2006","unstructured":"Sharma PK, Bhansali A, Sialy R, Malhotra S, Pandhi P. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus. Clin Endocrinol (Oxf). 2006, 65:722-8. 10.1111\/j.1365-2265.2006.02658.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1419","article-title":"Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program","volume":"57","author":"Mather KJ","year":"2008","unstructured":"Mather KJ, Funahashi T, Matsuzawa Y, et al.. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes. 2008, 57:980-6. 10.2337\/db07-1419","journal-title":"Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov A","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, et al.. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005, 115:1627-35. 10.1172\/JCI23606","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0229-9","article-title":"Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes","volume":"14","author":"Xiao Y","year":"2015","unstructured":"Xiao Y, Liu L, Xu A, et al.. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2015, 14:72. 10.1186\/s12933-015-0229-9","journal-title":"Cardiovasc Diabetol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/07435800.2011.558550","article-title":"Serum FGF-21 levels in type 2 diabetic patients","volume":"36","author":"Cheng X","year":"2011","unstructured":"Cheng X, Zhu B, Jiang F, Fan H. Serum FGF-21 levels in type 2 diabetic patients. Endocr Res. 2011, 36:142-8. 10.3109\/07435800.2011.558550","journal-title":"Endocr Res"},{"key":"ref7","article-title":"Inflammation and its association with vitamin D in newly diagnosed type 2 diabetes","volume":"4","author":"Kumar BJ","year":"2017","unstructured":"Kumar BJ, Itagappa M, Thimmaraju KV. Inflammation and its association with vitamin D in newly diagnosed type 2 diabetes. Int J Contemp Med Res. 2017, 4:1-5.","journal-title":"Int J Contemp Med Res"},{"key":"ref8","article-title":"Association of vitamin-D deficiency with oxidative stress in newly diagnosed type 2 diabetes","volume":"5","author":"Kumar BJ","year":"2017","unstructured":"Kumar BJ, Itaggappa M, Thimmaraju KV. Association of vitamin-D deficiency with oxidative stress in newly diagnosed type 2 diabetes. Int J Res Med Sci. 2017, 5:5221-6.","journal-title":"Int J Res Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-017-0189-z","article-title":"Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study","volume":"17","author":"Phosat C","year":"2017","unstructured":"Phosat C, Panprathip P, Chumpathat N, et al.. Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: a cross-sectional study. BMC Endocr Disord. 2017, 17:44. 10.1186\/s12902-017-0189-z","journal-title":"BMC Endocr Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2007.00710.x","article-title":"Role of vitamin D in the pathogenesis of type 2 diabetes mellitus","volume":"10","author":"Palomer X","year":"2008","unstructured":"Palomer X, Gonz\u00e1lez-Clemente JM, Blanco-Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008, 10:185-97. 10.1111\/j.1463-1326.2007.00710.x","journal-title":"Diabetes Obes Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20170042","article-title":"Vitamin D deficiency and diabetes","volume":"474","author":"Berridge MJ","year":"2017","unstructured":"Berridge MJ. Vitamin D deficiency and diabetes. Biochem J. 2017, 474:1321-32. 10.1042\/BCJ20170042","journal-title":"Biochem J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick MF","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96:1911-30. 10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105925","article-title":"Can vitamin D be considered an adiponectin secretagogue? A systematic review and meta-analysis","volume":"212","author":"Nikooyeh B","year":"2021","unstructured":"Nikooyeh B, Neyestani TR. Can vitamin D be considered an adiponectin secretagogue? A systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2021, 212:105925. 10.1016\/j.jsbmb.2021.105925","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref14","article-title":"Relationship between insulin resistance \"leptin to adiponectin ratio\" and vitamin D in patients with type 2 diabetes","volume":"10","author":"Najafipour M","year":"2020","unstructured":"Najafipour M, Zareizadeh E, Zareizadeh M, Shadroz S, Razaghi Z, Najafipour F. Relationship between insulin resistance \"leptin to adiponectin ratio\" and vitamin D in patients with type 2 diabetes. Int J Pharm Phytopharm Res. 2020, 10:37-41.","journal-title":"Int J Pharm Phytopharm Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.52711\/0974-360X.2022.00211","article-title":"Effect of vitamin D therapy on adiponectin level among type 2 diabetes mellitus patients","volume":"15","author":"Alkhaerow RA","year":"2022","unstructured":"Alkhaerow RA, Mohammad SH, Fadhil NN. Effect of vitamin D therapy on adiponectin level among type 2 diabetes mellitus patients. Res J Pharm Technol. 2022, 15:1263-6. 10.52711\/0974-360X.2022.00211","journal-title":"Res J Pharm Technol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.19082\/2849","article-title":"The effects of vitamin D supplementation on adiponectin level and insulin resistance in first-degree relatives of subjects with type 2 diabetes: a randomized double-blinded controlled trial","volume":"8","author":"Mohammadi SM","year":"2016","unstructured":"Mohammadi SM, Eghbali SA, Soheilikhah S, Ashkezari SJ, Salami M, Afkhami-Ardekani M, Afkhami-Ardekani A. The effects of vitamin D supplementation on adiponectin level and insulin resistance in first-degree relatives of subjects with type 2 diabetes: a randomized double-blinded controlled trial. Electron Physician. 2016, 8:2849-54. 10.19082\/2849","journal-title":"Electron Physician"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/a-1778-4159","article-title":"FGF21: a novel regulator of glucose and lipid metabolism and whole-body energy balance","volume":"54","author":"Szczepanska E","year":"2022","unstructured":"Szczepanska E, Gietka-Czernel M. FGF21: a novel regulator of glucose and lipid metabolism and whole-body energy balance. Horm Metab Res. 2022, 54:203-11. 10.1055\/a-1778-4159","journal-title":"Horm Metab Res"},{"key":"ref18","article-title":"Association between serum vitamin D level and glycemic and inflammatory markers in non-obese patients with type 2 diabetes","volume":"41","author":"Haidari F","year":"2016","unstructured":"Haidari F, Zakerkish M, Karandish M, Saki A, Pooraziz S. Association between serum vitamin D level and glycemic and inflammatory markers in non-obese patients with type 2 diabetes. Iran J Med Sci. 2016, 41:367-73.","journal-title":"Iran J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","unstructured":"Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010, 33.S62-9. 10.2337\/dc10-S062","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S003","article-title":"Standards of medical care in diabetes\u20142015: summary of revisions","volume":"38","year":"2014","unstructured":"Standards of medical care in diabetes\u20142015. summary of revisions. Diabetes Care. 2014, 38:S4. 10.2337\/dc15-S003","journal-title":"Diabetes Care"},{"key":"ref21","article-title":"Insulin resistance: disease or superpower?","volume":"11","author":"Maurer RN","year":"2021","unstructured":"Maurer RN. Insulin resistance: disease or superpower?. Endocrinology. 2021, 11:","journal-title":"Endocrinology"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.139242","article-title":"Pattern of 25 hydroxy vitamin D status in North Indian people with newly detected type 2 diabetes: a prospective case control study","volume":"18","author":"Laway BA","year":"2014","unstructured":"Laway BA, Kotwal SK, Shah ZA. Pattern of 25 hydroxy vitamin D status in North Indian people with newly detected type 2 diabetes: a prospective case control study. Indian J Endocrinol Metab. 2014, 18:726-30. 10.4103\/2230-8210.139242","journal-title":"Indian J Endocrinol Metab"},{"key":"ref23","article-title":"Prevalence of hypovitaminosis D in India & way forward","volume":"148","author":"Kamboj P","year":"2018","unstructured":"Kamboj P, Dwivedi S, Toteja GS. Prevalence of hypovitaminosis D in India & way forward. Indian J Med Res. 2018, 148:548-56.","journal-title":"Indian J Med Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-27302012000700003","article-title":"High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India","volume":"56","author":"Daga RA","year":"2012","unstructured":"Daga RA, Laway BA, Shah ZA, Mir SA, Kotwal SK, Zargar AH. High prevalence of vitamin D deficiency among newly diagnosed youth-onset diabetes mellitus in north India. Arq Bras Endocrinol Metabol. 2012, 56:423-8. 10.1590\/s0004-27302012000700003","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5187940","article-title":"Clinical applications of adiponectin measurements in type 2 diabetes mellitus: screening, diagnosis, and marker of diabetes control","volume":"2018","author":"Abdella NA","year":"2018","unstructured":"Abdella NA, Mojiminiyi OA. Clinical applications of adiponectin measurements in type 2 diabetes mellitus: screening, diagnosis, and marker of diabetes control. Dis Markers. 2018, 2018:5187940. 10.1155\/2018\/5187940","journal-title":"Dis Markers"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12095","article-title":"Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives","volume":"78","author":"Woo YC","year":"2013","unstructured":"Woo YC, Xu A, Wang Y, Lam KS. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. Clin Endocrinol (Oxf). 2013, 78:489-96. 10.1111\/cen.12095","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133228","article-title":"Adiponectin and cardiovascular risk. From pathophysiology to clinic: focus on children and adolescents","volume":"20","author":"Orlando A","year":"2019","unstructured":"Orlando A, Nava E, Giussani M, Genovesi S. Adiponectin and cardiovascular risk. From pathophysiology to clinic: focus on children and adolescents. Int J Mol Sci. 2019, 20:3228. 10.3390\/ijms20133228","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.12235","article-title":"Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention","volume":"9","author":"Gu L","year":"2021","unstructured":"Gu L, Jiang W, Qian H, Zheng R, Li W. Elevated serum FGF21 predicts the major adverse cardiovascular events in STEMI patients after emergency percutaneous coronary intervention. PeerJ. 2021, 9:e12235. 10.7717\/peerj.12235","journal-title":"PeerJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4161\/19381980.2014.983401","article-title":"Vitamin D and inflammation","volume":"6","author":"Cannell JJ","year":"2015","unstructured":"Cannell JJ, Grant WB, Holick MF. Vitamin D and inflammation. Dermatoendocrinol. 2015, 6:e983401. 10.4161\/19381980.2014.983401","journal-title":"Dermatoendocrinol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited","volume":"24","author":"Ceriello A","year":"2004","unstructured":"Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004, 24:816-23. 10.1161\/01.ATV.0000122852.22604.78","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24430","article-title":"Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes","volume":"36","author":"Gu J","year":"2022","unstructured":"Gu J, Wu Y, Huang W, et al.. Effect of vitamin D on oxidative stress and serum inflammatory factors in the patients with type 2 diabetes. J Clin Lab Anal. 2022, 36:e24430. 10.1002\/jcla.24430","journal-title":"J Clin Lab Anal"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.73","article-title":"Vitamin D and cardiovascular disease prevention","volume":"13","author":"Pilz S","year":"2016","unstructured":"Pilz S, Verheyen N, Gr\u00fcbler MR, Tomaschitz A, M\u00e4rz W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol. 2016, 13:404-17. 10.1038\/nrcardio.2016.73","journal-title":"Nat Rev Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306955-association-of-low-vitamin-d-status-with-adiponectin-and-fibroblast-growth-factor-21-in-newly-diagnosed-type-2-diabetes-mellitus-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:44:36Z","timestamp":1728920676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306955-association-of-low-vitamin-d-status-with-adiponectin-and-fibroblast-growth-factor-21-in-newly-diagnosed-type-2-diabetes-mellitus-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.71448","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}